Mary Chen

Mary Chen

Company: Actinium Pharmaceuticals

Job title: Vice President of Clinical Development


High Dose – Low Dose Therapeutic Strategy: Tailoring the Dose Of Radiopharmaceuticals For Opportunity And Outcomes 6:30 pm

Optimizing dose for new therapeutic opportunities Mechanistic combinations Navigating safety for improved outcomesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.